May 23, 2023
Main Stage
Sponsored By:
Speakers
Session Description
<div class="ag87-crtemvc-hsbk"><div class="css-vsf5of"><p class="carina-rte-public-DraftStyleDefault-block"><span style="color: rgb(0,0,0);">We are in the Age of Genetics. At last, we can address the underlying causes of disease after thousands of years of treating symptoms. Synthetic biology, founded on the ability to read, write, and run DNA, enables new therapeutic modalities to target and potentially cure our most challenging diseases. But what will it take for synbio therapeutics to become standard treatments? What challenges do we face in scaling, regulation, and adoption? What could the therapeutics landscape look like in the next 5 years? Join leading investors, academics, pharma executives, and synbio CEOs for a thought-provoking discussion on where the future of medicine will take us.</span></p></div></div>